Načítá se...
Effects of Risperidone and Galantamine treatment on Alzheimer biomarker levels in cerebrospinal fluid
BACKGROUND: Treatment for neuropsychiatric symptoms (NPS) in dementia is insufficient. Antipsychotics and acetylcholinesterase inhibitors are used generating symptomatic improvements in behaviour and cognition, but few studies have investigated their effect on Alzheimer biomarkers in cerebrospinal f...
Uloženo v:
| Vydáno v: | J Alzheimers Dis |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6203339/ https://ncbi.nlm.nih.gov/pubmed/28269767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-160758 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|